Predictors of Colorectal Cancer Screening Modality Among Newly Age-Eligible Medicaid Enrollees.

American Journal of Preventive Medicine
Cynthia M MojicaMelinda M Davis

Abstract

This study examines individual- and practice-level predictors of screening modality among 1,484 Medicaid enrollees who initiated colorectal cancer screening (fecal immunochemical test/fecal occult blood tests or colonoscopy) within a year of turning age 50 years. Understanding screening modality patterns for patients and health systems can help optimize colorectal cancer screening initiatives that will lead to high screening completion rates. Multivariable logistic regression was conducted in 2019 to analyze Medicaid claims data (January 2013-June 2015) to explore predictors of colonoscopy screening (versus fecal testing). Overall, 64% of enrollees received a colonoscopy and 36% received a fecal immunochemical test/fecal occult blood test. Male (OR=1.21, 95% CI=1.08, 1.37) compared with female enrollees and those with 4-6 (OR=1.57, 95% CI=1.15, 2.15), 7-10 (OR=2.23, 95% CI=1.64, 3.03), and ≥11 (OR=1.79, 95% CI=1.22, 2.65) primary care visits compared with 0-3 visits had higher odds of colonoscopy screening. Non-White, non-Hispanic enrollees (OR=0.71, 95% CI=0.58, 0.87) compared with White, non-Hispanics Whites had lower odds of colonoscopy screening. Practices with an endoscopy facility within their ZIP code (OR=1.50, 95% CI=1....Continue Reading

References

Feb 24, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Helen I MeissnerSally W Vernon
May 31, 2007·Journal of General Internal Medicine·Carrie N KlabundeSidney J Winawer
Jun 16, 2007·Gastroenterology·Nereo SegnanUNKNOWN SCORE3 Working Group-Italy
Oct 13, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Anna P SchenckDavid F Ransohoff
May 16, 2009·American Journal of Preventive Medicine·Carrie N KlabundeSally W Vernon
May 26, 2011·JAMA : the Journal of the American Medical Association·Chiang-Hua ChangDavid C Goodman
Apr 12, 2012·Archives of Internal Medicine·John M InadomiRodney A Hayward
May 15, 2013·The American Journal of Gastroenterology·Jennifer M WeissPatrick R Pfau
May 28, 2013·BMC Public Health·Paul RitvoLinda Rabeneck
Apr 1, 2014·Journal of the National Cancer Institute·Samir GuptaMaria Elena Martinez
May 6, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Karen J WernliCarolyn M Rutter
Sep 10, 2014·Journal of the American Board of Family Medicine : JABFM·Betty Y LiuPatricia A Carney
Dec 30, 2014·Healthcare : the Journal of Delivery Science and Innovation·K John McConnellJeanene Smith
Jan 19, 2015·Digestive Diseases and Sciences·Lyssa ChackoCarol A Burke
Sep 16, 2015·European Journal of Public Health·A WoolsJ R J de Leeuw
Mar 10, 2016·Journal of the American Board of Family Medicine : JABFM·Beverly B GreenSally W Vernon
Jun 10, 2016·Journal of General Internal Medicine·Ethan A HalmBijal A Balasubramanian
Jun 16, 2016·JAMA : the Journal of the American Medical Association·UNKNOWN US Preventive Services Task ForceAlbert L Siu
Feb 18, 2017·Preventive Medicine Reports·Stephanie B WheelerMichael P Pignone
Feb 24, 2017·Preventing Chronic Disease·Kristen Hassmiller LichStephanie B Wheeler
Apr 22, 2017·American Journal of Preventive Medicine·Stacey A FedewaChyke A Doubeni
Aug 16, 2017·World Journal of Gastroenterology : WJG·Iyad A Issa, Malak Noureddine
Sep 6, 2017·JAMA : the Journal of the American Medical Association·Michael Pignone, David P Miller
May 31, 2018·CA: a Cancer Journal for Clinicians·Andrew M D WolfRobert A Smith
Jan 23, 2019·BMC Health Services Research·Melinda M DavisStephanie B Wheeler
Dec 2, 2019·American Journal of Preventive Medicine·Cynthia M MojicaMelinda M Davis
Mar 13, 2020·MMWR. Morbidity and Mortality Weekly Report·Djenaba A JosephLisa C Richardson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.